NCT06191562

Brief Summary

The goal of this randomized clinical trial is to compare the results of ear tube placement in two different parts of the ear drum. The ear drum can be divided into four parts (called quadrants). Ear tubes are usually placed in one section of the ear drum, called the anterior-inferior quadrant. However, tubes can also be placed in another section, called the posterior-inferior quadrant. Ear tubes usually fall out of the ear drum on their own. In most patients, the hole in the ear drum where the tube used to be closes on its own. Sometimes (in about 2% of patients), the hole does not close on its own and might need surgery. We want to study ear tube placement in the posterior-inferior quadrant because surgery to repair a hole in the eardrum is easier in this location. For this study, children will receive an ear tube in the usual location (anterior-inferior quadrant) in one ear and the new location (posterior-inferior quadrant) in the other ear. Researchers will determine which ear has the new location using random assignment (like flipping a coin). Researchers will collect information about hearing tests, whether there is ear drainage (otorrhea), if the tube is blocked (occluded), and how the ear drum looks for up to 37 months after tube placement. Participants will answer study questions at 2-12 weeks and 6, 12, 18, 24, 30, and 36 months after surgery. These questions will ask about whether tubes have fallen out of the ear drum, whether there is a hole in the ear drum, whether there has been drainage from the ear or other ear symptoms, and whether there have been any visits to the doctor for ear problems. Researchers will use this information to compare ears with anterior-inferior tube placement and ears with posterior-inferior tube placement to see if there are differences in common complications following tube placement.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
386

participants targeted

Target at P75+ for not_applicable

Timeline
21mo left

Started Feb 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Feb 2024Feb 2028

First Submitted

Initial submission to the registry

December 19, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 5, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

February 29, 2024

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2028

Last Updated

February 20, 2026

Status Verified

February 1, 2026

Enrollment Period

3.9 years

First QC Date

December 19, 2023

Last Update Submit

February 17, 2026

Conditions

Keywords

Middle ear ventilationOtitis media

Outcome Measures

Primary Outcomes (1)

  • Perforation

    Percentage of ears with persistent (\>3 month) perforation of the tympanic membrane

    Within 36 months +/- 30 days following tympanostomy tube placement

Secondary Outcomes (14)

  • Parent-reported otorrhea at 2-12 weeks

    2-12 weeks following tympanostomy tube placement

  • Parent-reported otorrhea at 6 months

    6 months±30 days following tympanostomy tube placement

  • Provider-observed tube occlusion at 2-12 weeks

    2-12 weeks following tympanostomy tube placement

  • Provider-observed tube occlusion at 6 months

    6 months±30 days following tympanostomy tube placement

  • Provider-observed tympanostomy tubes in place and patent at 2-12 weeks

    2-12 weeks following tympanostomy tube placement

  • +9 more secondary outcomes

Other Outcomes (37)

  • Parent-reported otorrhea at 12 months

    12 months±30 days following tympanostomy tube placement

  • Parent-reported otorrhea at 18 months

    18 months±30 days following tympanostomy tube placement

  • Parent-reported otorrhea at 24 months

    24 months±30 days following tympanostomy tube placement

  • +34 more other outcomes

Study Arms (2)

Posterior Tympanostomy Tube Left

EXPERIMENTAL

Patients in whom the left ear is randomized to receive a tympanostomy tube in the posterior-inferior quadrant (new location).

Device: Tympanostomy tube

Posterior Tympanostomy Tube Right

EXPERIMENTAL

Patients in whom the right ear is randomized to receive a tympanostomy tube in the posterior-inferior quadrant (new location).

Device: Tympanostomy tube

Interventions

Participants will receive an ear tube in the usual location (anterior-inferior) in one ear and a new location (posterior-inferior) in the other ear during surgery.

Also known as: Myringotomy with tubes; pressure equalization tubes; ventilation tubes
Posterior Tympanostomy Tube LeftPosterior Tympanostomy Tube Right

Eligibility Criteria

Age6 Months - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Ages 6 months -14 years
  • Bilateral tympanostomy tube placement
  • First tympanostomy tubes placement
  • Indication for tympanostomy tube placement is otitis media

You may not qualify if:

  • Undergoing tympanostomy tube placement for indication other than otitis media
  • Receiving tubes other than Armstrong grommet.
  • Genetic disorder that impacts the craniofacial structure, immune system, or mucosal secretions such as Downs syndrome, Stickler syndrome, Treacher Collins syndrome, other genetic disorder associated with craniofacial anomalies, Severe Combined Immunodeficiency disorder, Cystic Fibrosis, or Primary Ciliary Dyskinesia
  • Patients with craniofacial abnormalities other than plagiocephaly or submucous cleft palate (SMCP)
  • Caregivers who cannot speak, read, or write in English proficiently
  • Prior or current otologic surgery other than tympanostomy tube placement
  • On systemic corticosteroids at the time of enrollment
  • Immunodeficiency (acquired or congenital)
  • Current retraction, cholesteatoma, or middle ear mass
  • Atresia
  • Sensorineural hearing loss
  • Known ossicular chain anomaly

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

UPMC Children's Hospital of Pittsburgh

Pittsburgh, Pennsylvania, 15224, United States

Location

UPMC Children's Hospital of Pittsburgh North

Sewickley, Pennsylvania, 15143, United States

Location

Related Publications (6)

  • ALBERTI PW. EPITHELIAL MIGRATION ON THE TYMPANIC MEMBRANE. J Laryngol Otol. 1964 Sep;78:808-30. doi: 10.1017/s0022215100062800. No abstract available.

    PMID: 14205963BACKGROUND
  • O'Donoghue GM. The kinetics of epithelial cells in relation to ventilating tubes. Acta Otolaryngol. 1984 Jul-Aug;98(1-2):105-9. doi: 10.3109/00016488409107541.

    PMID: 6380208BACKGROUND
  • Gibb AG, Mackenzie IJ. The extrusion rate of grommets. Otolaryngol Head Neck Surg. 1985 Dec;93(6):695-9. doi: 10.1177/019459988509300601.

    PMID: 3937089BACKGROUND
  • Kivekas I, Poe D. Is there an optimal location for tympanostomy tube placement? Laryngoscope. 2015 Jul;125(7):1513-4. doi: 10.1002/lary.25127. Epub 2015 Jan 13. No abstract available.

    PMID: 25582620BACKGROUND
  • Mehta RP, Rosowski JJ, Voss SE, O'Neil E, Merchant SN. Determinants of hearing loss in perforations of the tympanic membrane. Otol Neurotol. 2006 Feb;27(2):136-43. doi: 10.1097/01.mao.0000176177.17636.53.

    PMID: 16436981BACKGROUND
  • Stinson WD. Reparative processes in the membrana tympani: some interested manifestations. Arch Otolaryngol. 1936; 24(5): 600-605. doi:10.1001/archotol.1936.00640050613006.

    BACKGROUND

MeSH Terms

Conditions

Otitis Media

Interventions

Middle Ear Ventilation

Condition Hierarchy (Ancestors)

OtitisEar DiseasesOtorhinolaryngologic Diseases

Intervention Hierarchy (Ancestors)

OstomySurgical Procedures, OperativeOtologic Surgical ProceduresOtorhinolaryngologic Surgical Procedures

Study Officials

  • David H Chi, MD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Experimental, randomized control trial with no placebo
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 19, 2023

First Posted

January 5, 2024

Study Start

February 29, 2024

Primary Completion (Estimated)

February 1, 2028

Study Completion (Estimated)

February 1, 2028

Last Updated

February 20, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Individual participant data (IPD) that underlie the results reported in a publication may be shared, after de-identification.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Beginning 1 year after publication of summary data. Ending 5 years after publication.
Access Criteria
IPD will be shared with researchers who provide a methodologically sound proposal. IPD to be shared will include that necessary to achieve the aims in the approved proposal. Proposals should be directed to shafferad@upmc.edu. To gain access, data requestors will need to sign data access agreement.

Locations